Eosinophilic cellulitis in response to BNT162b2 COVID‐19 vaccination
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric Dermatology"
DOI: 10.1111/pde.15019
Abstract: A 12‐year‐old boy presented with a 2‐week history of persistent pruritic edematous plaques one day after he received the first dose of the BNT162b2 COVID‐19 mRNA vaccine. A skin biopsy showed urticarial dermatitis with tissue… read more here.
Keywords: bnt162b2 covid; cellulitis response; eosinophilic cellulitis;